Cells as delivery vehicles for cancer therapeutics.

Cell-based therapeutics have advanced significantly over the past decade and are poised to become a major pillar of modern medicine. Three cell types in particular have been studied in detail for their ability to home to tumors and to deliver a variety of different payloads. Neural stem cells, mesenchymal stem cells and monocytes have each been shown to have great potential as future delivery systems for cancer therapy. A variety of other cell types have also been studied. These results demonstrate that the field of cell-based therapeutics will only continue to grow.

[1]  L. Naldini,et al.  Tie2-expressing monocytes (TEMs): novel targets and vehicles of anticancer therapy? , 2009, Biochimica et biophysica acta.

[2]  M. Babič,et al.  Human adipose tissue‐derived mesenchymal stem cells expressing yeast cytosinedeaminase::uracil phosphoribosyltransferase inhibit intracerebral rat glioblastoma , 2012, International journal of cancer.

[3]  P. Black,et al.  Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[4]  V. Altanerová,et al.  Complete regression of glioblastoma by mesenchymal stem cells mediated prodrug gene therapy simulating clinical therapeutic scenario , 2014, International journal of cancer.

[5]  G. Lin,et al.  Effects of transplantation of adipose tissue‐derived stem cells on prostate tumor , 2010, The Prostate.

[6]  B. Tannous,et al.  Advances in stem cell therapy against gliomas. , 2013, Trends in molecular medicine.

[7]  Thomas M. Schmitt,et al.  The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor. , 2010, Blood.

[8]  E. Fuentes-Pananá,et al.  Protumor Activities of the Immune Response: Insights in the Mechanisms of Immunological Shift, Oncotraining, and Oncopromotion , 2013, Journal of oncology.

[9]  M. Matúšková,et al.  Tumor cell behaviour modulation by mesenchymal stromal cells , 2010, Molecular Cancer.

[10]  G. Coukos,et al.  In vivo persistence, tumor localization, and antitumor activity of CAR-engineered T cells is enhanced by costimulatory signaling through CD137 (4-1BB). , 2011, Cancer research.

[11]  L. Skivka,et al.  5-aminolevulinic acid mediated photodynamic therapy of Lewis lung carcinoma: a role of tumor infiltration with different cells of immune system. , 2004, Experimental oncology.

[12]  Lindsay J. Georgopoulos,et al.  Use of macrophages to target therapeutic adenovirus to human prostate tumors. , 2011, Cancer research.

[13]  M. Andreeff,et al.  Origins of the Tumor Microenvironment: Quantitative Assessment of Adipose-Derived and Bone Marrow–Derived Stroma , 2012, PloS one.

[14]  Luigi Naldini,et al.  Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. , 2005, Cancer cell.

[15]  M. Lamfers,et al.  Homing properties of adipose-derived stem cells to intracerebral glioma and the effects of adenovirus infection. , 2009, Cancer letters.

[16]  Anatol C. Kreitzer,et al.  Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor. , 2012, Cell stem cell.

[17]  G. Rossi,et al.  Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy. , 2010, Cancer research.

[18]  S. Saccani,et al.  Regulation of the Chemokine Receptor CXCR4 by Hypoxia , 2003, The Journal of experimental medicine.

[19]  C. Jacobi,et al.  Induction of M2-macrophages by tumour cells and tumour growth promotion by M2-macrophages: a quid pro quo in pancreatic cancer. , 2013, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[20]  Tej B. Shrestha,et al.  Cell-delivered magnetic nanoparticles caused hyperthermia-mediated increased survival in a murine pancreatic cancer model , 2012, International journal of nanomedicine.

[21]  Tej B. Shrestha,et al.  A cell-delivered and cell-activated SN38-dextran prodrug increases survival in a murine disseminated pancreatic cancer model. , 2012, Small.

[22]  D. Curiel,et al.  Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses , 2006, Molecular Cancer Therapeutics.

[23]  J. Kuratsu,et al.  TGF-β mediates homing of bone marrow-derived human mesenchymal stem cells to glioma stem cells. , 2013, Cancer research.

[24]  Tej B. Shrestha,et al.  A self-contained enzyme activating prodrug cytotherapy for preclinical melanoma , 2011, Molecular Biology Reports.

[25]  Yi Wang,et al.  Inhibition of neuronal nitric oxide synthase activity promotes migration of human‐induced pluripotent stem cell‐derived neural stem cells toward cancer cells , 2013, Journal of neurochemistry.

[26]  Atique U. Ahmed,et al.  Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: Targeted delivery of the therapeutic payload in an orthotopic brain tumor model , 2012, Cancer Gene Therapy.

[27]  Steen J. Madsen,et al.  Photothermal treatment of glioma; an in vitro study of macrophage-mediated delivery of gold nanoshells , 2011, Journal of Neuro-Oncology.

[28]  V. Altanerová,et al.  Stem cell based cancer gene therapy. , 2011, Molecular pharmaceutics.

[29]  H. Gendelman,et al.  A macrophage-nanozyme delivery system for Parkinson's disease. , 2007, Bioconjugate chemistry.

[30]  Gang Li,et al.  Immortalized human fetal bone marrow-derived mesenchymal stromal cell expressing suicide gene for anti-tumor therapy in vitro and in vivo. , 2013, Cytotherapy.

[31]  M. Andreeff,et al.  Concise Review: Dissecting a Discrepancy in the Literature: Do Mesenchymal Stem Cells Support or Suppress Tumor Growth? , 2010, Stem cells.

[32]  Yuan Yang,et al.  The immunomodulatory activity of human umbilical cord blood‐derived mesenchymal stem cells in vitro , 2009, Immunology.

[33]  K. Iwami,et al.  Neural stem cell-based dual suicide gene delivery for metastatic brain tumors , 2012, Cancer Gene Therapy.

[34]  Michel Sadelain,et al.  Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias. , 2011, Blood.

[35]  Lei Shi,et al.  Use of Thymidine Kinase Gene-Modified Endothelial Progenitor Cells as a Vector Targeting Angiogenesis in Glioma Gene Therapy , 2010, Oncology.

[36]  Y. Kodera,et al.  Targeted delivery of oligomannose‐coated liposome to the omental micrometastasis by peritoneal macrophages from patients with gastric cancer , 2010, Cancer science.

[37]  M. Weiss,et al.  Combination Treatment of Human Umbilical Cord Matrix Stem Cell-Based Interferon-Beta Gene Therapy and 5-Fluorouracil Significantly Reduces Growth of Metastatic Human Breast Cancer in SCID Mouse Lungs , 2008, Cancer investigation.

[38]  S. Bossmann,et al.  Attenuation of mouse melanoma by A/C magnetic field after delivery of bi-magnetic nanoparticles by neural progenitor cells. , 2010, ACS nano.

[39]  P. Potter,et al.  Development of a Tumor-Selective Approach to Treat Metastatic Cancer , 2006, PloS one.

[40]  J. Dobson,et al.  A novel magnetic approach to enhance the efficacy of cell-based gene therapies , 2008, Gene Therapy.

[41]  M. Andreeff,et al.  Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. , 2005, Cancer research.

[42]  A. Wu,et al.  Neural Stem Cells as a Novel Platform for Tumor-Specific Delivery of Therapeutic Antibodies , 2009, PloS one.

[43]  Č. Altaner.  Prodrug cancer gene therapy. , 2008, Cancer letters.

[44]  H. Wakimoto,et al.  A dual PI3K/mTOR inhibitor, PI-103, cooperates with stem cell-delivered TRAIL in experimental glioma models. , 2011, Cancer research.

[45]  Keith M. Stantz,et al.  Delivery of nanoparticles to brain metastases of breast cancer using a cellular Trojan horse , 2012, Cancer Nanotechnology.

[46]  S. Russell,et al.  The utility of cells as vehicles for oncolytic virus therapies. , 2008, Current opinion in molecular therapeutics.

[47]  Andrea Falini,et al.  Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis. , 2008, Cancer cell.

[48]  P. Schiller,et al.  Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors. , 2010, Biomaterials.

[49]  Jennifer Sturgis,et al.  A cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors. , 2007, Nano letters.

[50]  F. Nepveu,et al.  Extracts of Crinum latifolium inhibit the cell viability of mouse lymphoma cell line EL4 and induce activation of anti-tumour activity of macrophages in vitro. , 2013, Journal of ethnopharmacology.

[51]  C. Divino,et al.  Myeloid-derived suppressor cells as a vehicle for tumor-specific oncolytic viral therapy. , 2013, Cancer research.

[52]  M. Andreeff,et al.  Tumor stroma engraftment of gene-modified mesenchymal stem cells as anti-tumor therapy against ovarian cancer. , 2013, Cytotherapy.

[53]  C. Ries,et al.  In Vitro Generation of Monocyte-Derived Macrophages under Serum-Free Conditions Improves Their Tumor Promoting Functions , 2012, PloS one.

[54]  W. Weimar,et al.  Culture expansion induces non-tumorigenic aneuploidy in adipose tissue-derived mesenchymal stromal cells. , 2013, Cytotherapy.

[55]  Z. Eshhar,et al.  Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Atique U. Ahmed,et al.  A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma. , 2011, Molecular pharmaceutics.

[57]  Chenfang Dong,et al.  Gene therapy of gastric cancer using LIGHT-secreting human umbilical cord blood-derived mesenchymal stem cells , 2013, Gastric Cancer.

[58]  M. Korbelik,et al.  Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy. , 1995, British Journal of Cancer.

[59]  M. N. Margolies,et al.  Expression of a hybrid immunoglobulin-T cell receptor protein in transgenic mice , 1989, Cell.

[60]  J. Yoshida,et al.  Human neural stem cells target and deliver therapeutic gene to experimental leptomeningeal medulloblastoma , 2007, Gene Therapy.

[61]  M. Weiss,et al.  Rat umbilical cord stem cells completely abolish rat mammary carcinomas with no evidence of metastasis or recurrence 100 days post-tumor cell inoculation. , 2009, Cancer research.

[62]  H. Klassen,et al.  Neural Progenitor Cells Lack Immunogenicity and Resist Destruction as Allografts , 2003, Stem cells.

[63]  E. Choi,et al.  Use of macrophages to deliver therapeutic and imaging contrast agents to tumors. , 2012, Biomaterials.

[64]  J. Mathis,et al.  Mesenchymal Stem Cells Effectively Deliver an Oncolytic Adenovirus to Intracranial Glioma , 2008, Stem cells.

[65]  M. Andreeff,et al.  Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. , 2002, Cancer research.

[66]  S. Yaccoby,et al.  Therapeutic effects of intrabone and systemic mesenchymal stem cell cytotherapy on myeloma bone disease and tumor growth , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[67]  J. Russell,et al.  The irradiated tumor microenvironment: role of tumor-associated macrophages in vascular recovery , 2013, Front. Physiol..

[68]  A. Doseff,et al.  Regulation of monocytes and macrophages cell fate. , 2009, Frontiers in bioscience.

[69]  Atique U. Ahmed,et al.  Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[70]  David L. Porter,et al.  T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia , 2011, Science Translational Medicine.

[71]  D. Campana,et al.  Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[72]  P. Brachet,et al.  Immunoregulatory properties of neural stem cells. , 2011, Immunotherapy.

[73]  J. Itskovitz‐Eldor,et al.  Human embryonic stem cells: A potential source for cellular therapy , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[74]  R. Lerner,et al.  Autocrine signaling based selection of combinatorial antibodies that transdifferentiate human stem cells , 2013, Proceedings of the National Academy of Sciences.

[75]  F. Klamt,et al.  The prognostic impact of tumor-associated macrophages and intra-tumoral apoptosis in non-small cell lung cancer. , 2014, Histology and histopathology.

[76]  P. van Endert,et al.  Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells. , 2013, Immunity.

[77]  K. Vanderkerken,et al.  Bone Marrow‐Derived Mesenchymal Stromal Cells are Attracted by Multiple Myeloma Cell‐Produced Chemokine CCL25 and Favor Myeloma Cell Growth in Vitro and In Vivo , 2012, Stem cells.

[78]  E. Wang,et al.  Macrophage polarization induced by neuropeptide methionine enkephalin (MENK) promotes tumoricidal responses , 2012, Cancer Immunology, Immunotherapy.

[79]  J. Berlin,et al.  Gold Nanoparticle‐Loaded Neural Stem Cells for Photothermal Ablation of Cancer , 2013, Advanced healthcare materials.

[80]  I. Balyasnikova,et al.  Therapeutic effect of neural stem cells expressing TRAIL and bortezomib in mice with glioma xenografts. , 2011, Cancer letters.

[81]  T. He,et al.  LIGHT delivery to tumors by mesenchymal stem cells mobilizes an effective antitumor immune response. , 2012, Cancer research.

[82]  Z. Eshhar,et al.  Generation of effector T cells expressing chimeric T cell receptor with antibody type-specificity. , 1989, Transplantation proceedings.

[83]  A. Vessières,et al.  Ferrociphenol lipid nanocapsule delivery by mesenchymal stromal cells in brain tumor therapy. , 2012, International journal of pharmaceutics.

[84]  J. Mesirov,et al.  Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. , 2008, Cancer research.

[85]  J. Prieto,et al.  Evaluation of monocytes as carriers for armed oncolytic adenoviruses in murine and Syrian hamster models of cancer. , 2012, Human gene therapy.

[86]  A. Dietz,et al.  Mesenchymal Stem Cell Carriers Protect Oncolytic Measles Viruses from Antibody Neutralization in an Orthotopic Ovarian Cancer Therapy Model , 2009, Clinical Cancer Research.

[87]  Wendell A. Lim,et al.  Cell-Based Therapeutics: The Next Pillar of Medicine , 2013, Science Translational Medicine.

[88]  Atique U. Ahmed,et al.  The Timing of Neural Stem Cell‐Based Virotherapy Is Critical for Optimal Therapeutic Efficacy When Applied With Radiation and Chemotherapy for the Treatment of Glioblastoma , 2013, Stem cells translational medicine.

[89]  Rahul Kumar,et al.  Computational approach for designing tumor homing peptides , 2013, Scientific Reports.

[90]  C. Cambouris,et al.  Anti-tumor properties of human-activated macrophages produced in large scale for clinical application. , 2005, Immunobiology.

[91]  S. Vandenberg,et al.  HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. , 2008, Cancer cell.

[92]  M. Raffeld,et al.  Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma , 2006, The Journal of experimental medicine.

[93]  M. Matúšková,et al.  Adipose tissue-derived mesenchymal stem cells expressing prodrug-converting enzyme inhibit human prostate tumor growth. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[94]  M. Matúšková,et al.  Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice , 2008, The journal of gene medicine.

[95]  M. Westphal,et al.  Intranasal Delivery of Neural Stem/Progenitor Cells: A Noninvasive Passage to Target Intracerebral Glioma , 2012, Stem cells translational medicine.

[96]  M. Weiss,et al.  Development of human umbilical cord matrix stem cell-based gene therapy for experimental lung tumors , 2007, Cancer Gene Therapy.

[97]  M. Penn,et al.  Development of a peptide-targeted, myocardial ischemia-homing, mesenchymal stem cell , 2012, Journal of drug targeting.

[98]  Ghayathri Balasundaram,et al.  Retracted: Tumor Tropism of Intravenously Injected Human‐Induced Pluripotent Stem Cell‐Derived Neural Stem Cells and Their Gene Therapy Application in a Metastatic Breast Cancer Model , 2012, Stem cells.

[99]  L. Kanz,et al.  Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin. , 1992, Blood.

[100]  H. Wakimoto,et al.  Therapeutic stem cells expressing variants of EGFR-specific nanobodies have antitumor effects , 2012, Proceedings of the National Academy of Sciences.

[101]  Y. Kurosawa,et al.  Expression of chimeric receptor composed of immunoglobulin-derived V regions and T-cell receptor-derived C regions. , 1987, Biochemical and biophysical research communications.